US2019331678A1PendingUtilityA1

Genetically encoded biosensors

Assignee: HUGHES HOWARD MED INSTPriority: Oct 7, 2011Filed: Jul 2, 2019Published: Oct 31, 2019
Est. expiryOct 7, 2031(~5.2 yrs left)· nominal 20-yr term from priority
G01N 33/557G01N 33/582G01N 2400/00C07K 14/43595C07K 2319/60C07K 14/245C07K 2319/24C07K 2319/20G01N 33/6812C07K 14/195G01N 33/68G01N 2458/00
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides, inter alia, genetically encoded recombinant peptide biosensors comprising analyte-binding framework portions and signaling portions, wherein the signaling portions are present within the framework portions at sites or amino acid positions that undergo a conformational change upon interaction of the framework portion with an analyte.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A recombinant peptide biosensor comprising an analyte-binding framework portion and a signaling portion, wherein the signaling portion is present within the framework portion at a site or amino acid position that undergoes a conformational change upon interaction of the framework portion with a defined, specific, or selected analyte.

Join the waitlist — get patent alerts

Track US2019331678A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.